补阳还五汤与卒中后糖尿病风险:全国倾向评分匹配研究
基于台湾大规模保险数据库的回顾性队列研究,纳入2000至2004年新诊断卒中住院患者,经倾向评分匹配后补阳还五汤组与对照组各9849例,随访至2009年。补阳还五汤组糖尿病发生率14.1%低于对照组19.0%(p<0.0001),糖尿病风险降低(HR 0.77;95%CI 0.72-0.83),在不同性别、年龄组和卒中亚型中均显著。
要点
- 使用补阳还五汤的卒中患者糖尿病发生率14.1%,低于对照组的19.0%。
- 补阳还五汤与卒中后糖尿病风险降低相关,HR 0.77(95%CI 0.72-0.83)。
- 该关联在性别、年龄组和卒中亚型中均显著,敏感性分析排除初始三个月病例后仍存在。
核心结论
- 接受补阳还五汤治疗的卒中患者糖尿病风险降低,且在多个亚组中观察到积极效果。
- 研究结论需未来临床试验验证并明确涉及的生化机制。
研究设计与样本
- 基于真实世界数据库的回顾性队列研究。
- 使用台湾大规模保险数据库识别2000至2004年新诊断卒中住院患者。
- 倾向评分匹配后补阳还五汤组9849例、对照组9849例,随访至2009年底追踪新发糖尿病。
- 采用Cox比例风险模型计算调整后风险比(HR)及95%置信区间(CI)。
主要发现
- 补阳还五汤组糖尿病发生率为14.1%,对照组为19.0%(p<0.0001)。
- 补阳还五汤与卒中后糖尿病风险降低相关,HR 0.77(95%CI 0.72-0.83)。
- 补阳还五汤与卒中后糖尿病风险降低的关联在性别、年龄组和卒中亚型中均显著。
- 敏感性分析排除初始三个月糖尿病病例后,补阳还五汤仍与卒中后糖尿病风险降低相关。
临床怎么用
- 对于卒中患者,可考虑在中医辨证指导下使用补阳还五汤,并关注血糖变化。
- 该研究提示补阳还五汤可能有助于降低卒中后糖尿病风险,但需结合患者个体情况。
局限性
- 研究为回顾性队列研究,可能存在未测量的混杂因素。
- 结论需未来临床试验验证,并需明确生化机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The utilization of traditional Chinese medicine is a common therapeutic approach for stroke patients in Chinese population, but little is known about the effect of Bu Yang Huan Wu Tang (BYHWT) on post-stroke diabetes. PURPOSE: We aimed to evaluate the risk of diabetes in stroke patients who used BYHWT. STUDY DESIGN: A retrospective cohort study based on a real-world database was conducted. METHODS: Newly diagnosed stroke patients receiving inpatient care from 2000 to 2004 were identified using a large-scale insurance database in Taiwan. Propensity score matching was used to select eligible stroke patients who did (n = 9849) and did not (n = 9849) receive BYHWT. These two groups were followed up until the end of 2009 to track incident diabetes. Cox proportional hazard models were used to calculate the adjusted hazard rations (HRs) and 95% confidence intervals (CIs) for post-stroke diabetes associated with BYHWT during the follow-up period. RESULTS: Stroke patients who used BYHWT had a reduced incidence of diabetes (14.1% vs. 19.0%, p < 0.0001) and reduced risk of diabetes (HR 0.77; 95% CI 0.72 to 0.83) compared with the control group. The association between BYHWT and reduced risk of post-stroke diabetes was significant across sexe, age group, and stroke subtype. Additionally, the use of BYHWT was associated with a reduced risk of post-stroke diabetes even after excluding the initial three months of diabetes cases in the sensitivity analysis. CONCLUSIONS: Stroke patients who received BYHWT therapy had a reduced risk of diabetes, and a positive effect was observed in various subgroups. However, future clinical trials will be necessary to validate the present findings and identify the biochemical mechanism involved.
引用
- Weng SW, Chang CC, Chen TL, et al. Risk of diabetes in stroke patients who used Bu Yang Huan Wu Tang: A nationwide propensity-score matched study. Phytomedicine. 2020. PMID: 33086171. doi:10.1016/j.phymed.2020.153376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。